Detection of superoxide dismutase-1 in nipple aspirate fluids: A reactive oxygen species-regulating enzyme in the breast cancer microenvironment

Clinical Breast Cancer

Volumn 10, Issue 3, 2010, Pages 238-245

  Mannello, Ferdinando ^a   Tonti, Gaetana A ^a   Pederzoli, Andrea ^b   Simone, Patrizia ^a   Smaniotto, Alessandra ^a   Medda, Virginia ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Infermi Hospital   (Italy)

Author keywords

NAF; Oxidative stress; ROS; SOD 1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOSOL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MICROENVIRONMENT; NIPPLE ASPIRATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77952970259     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2010.n.032     Document Type: Article

References (45)

1. Azzi A. Oxidative stress: a dead end or a laboratory hypothesis? Biochem Biophys Res Commun 2007; 362:230-232
2. Ottaviano FG, Handy DE, Loscalzo J. Redox regulation in the extracellular environment. Circ J 2008; 72:1-16.
3. Seifried HE. Oxidative stress and antioxidants: a link to disease and prevention? J Nutr Biochem 2007; 18:168-171
4. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44-84.
5. Galli F, Piroddi M, Annetti C, et al. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005; 149:240-260
6. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-247
7. Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17:1195-1214 (Pubitemid 36775767)
8. Polat MF, Taysi S, Gul M, et al. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002; 20:327-331
9. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002; 33:337-349
10. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003; 35:236-256
11. Sinha RJ, Singh R, Mehrotra S, et al. Implications of free radicals and antioxidant levels in carcinoma of the breast: a never-ending battle for survival. Indian J Cancer 2009; 46:146-150
12. Weydert CJ, Waugh TA, Ritchie JM, et al. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med 2006; 41:226-237
13. Arslantas A. Development of functional models for a SOD. Met Based Drugs 2002; 9:9-18.
14. Pervaiz S, Clement MV. Superoxide anion: oncogenic reactive oxygen species? Int J Biochem Cell Biol 2007; 39:1297-1304
15. Mannello F. Analysis of the intraductal microenvironment for the early diagnosis of breast cancer: identification of biomarkers in nipple-aspirate fluids. Expert Opin Med Diagn 2008; 2:1121-1231.
16. Mannello F, Tonti GA, Qin W, et al. Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development? Breast Cancer Res Treat 2007; 102:125-127
17. Mannello F, Medda V, Tonti GA. Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Rev Proteomics 2009; 6:43-60.
18. Mannello F, Medda V, Smaniotto A, et al. Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer. Expert Rev Endocricol Metab 2009; 4:493-505.
19. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006; 56:37-47.
20. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997; 16:791-801.
21. Ray G, Husain SA. Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol 2002; 40:1213-1232
22. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann N Y Acad Sci 2000; 908:219-225
23. Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32:595-603.
24. Mates JM, Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999; 4:D339-45.
25. Kumaraguruparan R, Subapriya R, Viswanathan P, et al. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta 2002; 325:165-170 (Pubitemid 35279640)
26. Kumaraguruparan R, Subapriya R, Kabalimoorthy J, et al. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35:275-279 (Pubitemid 34804896)
27. Ray G, Batra S, Shukla NK, et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 2000; 59:163-170
28. Tas F, Hansel H, Belce A, et al. Oxidative stress in breast cancer. Med Oncol 2005; 22:11-15
29. Buettner GR, Ng CF, Wang M, et al. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic Biol Med 2006; 41:1338-1350
30. Ridnour LA, Oberley TD, Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal 2004; 6:501-512
31. Li Z, Khaletskiy A, Wang J, et al. Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase. Free Radic Biol Med 2001; 30:260-267
32. Miller DM, Buettner GR, Aust SD. Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med 1990; 8:95-108.
33. Kumar K, Thangaraju M, Sachdanandam P. Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochem Int 1991; 25:371-380
34. Seven A, Erbil Y, Seven R, et al. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem Biophys 1998; 16:333-345
35. Abiaka C, Al-Awadi F, Al-Sayer H, et al. Activities of erythrocyte antioxidant enzymes in cancer patients. J Clin Lab Anal 2002; 16:167-171
36. Yeh CC, Hou MF, Tsai SM, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 2005; 361:104-111
37. Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38:154-158
38. Mannello F, Qin W, Zhu W, et al. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2. Breast Cancer Res Treat 2008; 111:209-218
39. Mannello F, Tonti GA, Pagliarani S, et al. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer 2007; 120:1971-1976.
40. Poulsen HE. Oxidative DNA modifications. Exp Toxicol Pathol 2005; 57(suppl 1):161-169
41. Lu F. Reactive oxygen species in cancer, too much or too little? Med Hypotheses 2007; 69:1293-1298
42. Lu W, Ogasawara MA, Huang P. Models of reactive oxygen species in cancer. Drug Discov Today Dis Models 2007; 4:67-73.
43. Burdon RH. Control of cell proliferation by reactive oxygen species. Biochem Soc Trans 1996; 24:1028-1032
44. Mates JM, Segura JA, Alonso FJ, et al. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 2008; 82:273-299
45. Lau AT, Wang Y, Chiu JF. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 2008; 104:657-667